143 related articles for article (PubMed ID: 34599991)
1. Syringic acid demonstrates promising protective effect against tau fibrillization and cytotoxicity through regulation of endoplasmic reticulum stress-mediated pathway as a prelude to Alzheimer's disease.
Li X; Zhang X; Xing R; Qi F; Dong J; Li D; Tian X; Yu B; Huang M; Zhang L; Yuan X; Yang Y; Wu H; Zang L; Mao X; Sui R
Int J Biol Macromol; 2021 Dec; 192():491-497. PubMed ID: 34599991
[TBL] [Abstract][Full Text] [Related]
2. Exploring the inhibitory effects of liquiritigenin against tau fibrillation and related neurotoxicity as a model of preventive care in Alzheimer's disease.
Yuan X; Wang Z; Zhang L; Sui R; Khan S
Int J Biol Macromol; 2021 Jul; 183():1184-1190. PubMed ID: 33965487
[TBL] [Abstract][Full Text] [Related]
3. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells.
Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY; Chan EWL
J Ethnopharmacol; 2018 May; 217():187-194. PubMed ID: 29462698
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tau aggregation and associated cytotoxicity on neuron-like cells by calycosin.
Zhenxia Z; Min L; Peikui Y; Zikai C; Yaqun L; Junli W; Fenlian Y; Yuzhong Z
Int J Biol Macromol; 2021 Feb; 171():74-81. PubMed ID: 33301850
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of heptelidic acid as a potential inhibitor for tau aggregation-induced Alzheimer's disease and associated neurotoxicity.
Zhang L; Wang Z; Yuan X; Sui R; Falahati M
Int J Biol Macromol; 2021 Jul; 183():1155-1161. PubMed ID: 33971235
[TBL] [Abstract][Full Text] [Related]
6. Pathological concentration of zinc dramatically accelerates abnormal aggregation of full-length human Tau and thereby significantly increases Tau toxicity in neuronal cells.
Hu JY; Zhang DL; Liu XL; Li XS; Cheng XQ; Chen J; Du HN; Liang Y
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):414-427. PubMed ID: 27890528
[TBL] [Abstract][Full Text] [Related]
7. The combination of 1α,25dihydroxyvitaminD3 with resveratrol improves neuronal degeneration by regulating endoplasmic reticulum stress, insulin signaling and inhibiting tau hyperphosphorylation in SH-SY5Y cells.
Cheng J; Xia X; Rui Y; Zhang Z; Qin L; Han S; Wan Z
Food Chem Toxicol; 2016 Jul; 93():32-40. PubMed ID: 27133915
[TBL] [Abstract][Full Text] [Related]
8. Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.
Jouanne M; Rault S; Voisin-Chiret AS
Eur J Med Chem; 2017 Oct; 139():153-167. PubMed ID: 28800454
[TBL] [Abstract][Full Text] [Related]
9. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
[TBL] [Abstract][Full Text] [Related]
10. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
[TBL] [Abstract][Full Text] [Related]
11. Ser
Sandhu P; Naeem MM; Lu C; Kumarathasan P; Gomes J; Basak A
Bioorg Med Chem Lett; 2017 Feb; 27(3):642-652. PubMed ID: 27989667
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Tau Protein Aggregation by Rhodanine-based Compounds Solubilized Via Specific Formulation Additives to Improve Bioavailability and Cell Viability.
Pickhardt M; Lawatscheck C; Borner HG; Mandelkow E
Curr Alzheimer Res; 2017; 14(7):742-752. PubMed ID: 28155596
[TBL] [Abstract][Full Text] [Related]
13. Interplay of isoform 1N4R tau protein and amyloid-β peptide fragment 25-35 in reducing and non-reducing conditions.
Mohammadi F; Takalloo Z; Rahmani H; Nasiri Khalili MA; Khajeh K; Riazi G; H Sajedi R
J Biochem; 2021 Feb; 169(1):119-134. PubMed ID: 32857841
[TBL] [Abstract][Full Text] [Related]
14. The multifunctional dopamine D
Ziu I; Rettig I; Luo D; Dutta A; McCormick TM; Wu C; Martic S
Bioorg Med Chem; 2020 Sep; 28(18):115667. PubMed ID: 32828429
[TBL] [Abstract][Full Text] [Related]
15. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.
García-Font N; Hayour H; Belfaitah A; Pedraz J; Moraleda I; Iriepa I; Bouraiou A; Chioua M; Marco-Contelles J; Oset-Gasque MJ
Eur J Med Chem; 2016 Aug; 118():178-92. PubMed ID: 27128182
[TBL] [Abstract][Full Text] [Related]
16. Screening strategies to identify HSP70 modulators to treat Alzheimer's disease.
Repalli J; Meruelo D
Drug Des Devel Ther; 2015; 9():321-31. PubMed ID: 25609918
[TBL] [Abstract][Full Text] [Related]
17. Tau/Aβ chimera peptides: A Thioflavin-T and MALDI-TOF study of Aβ amyloidosis in the presence of Cu(II) or Zn(II) ions and total lipid brain extract (TLBE) vesicles.
Sciacca MFM; Di Natale G; Milardi D; Pappalardo G
Chem Phys Lipids; 2021 Jul; 237():105085. PubMed ID: 33895131
[TBL] [Abstract][Full Text] [Related]
18. Inert and seed-competent tau monomers suggest structural origins of aggregation.
Mirbaha H; Chen D; Morazova OA; Ruff KM; Sharma AM; Liu X; Goodarzi M; Pappu RV; Colby DW; Mirzaei H; Joachimiak LA; Diamond MI
Elife; 2018 Jul; 7():. PubMed ID: 29988016
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of amyloid fibril formation and cytotoxicity by caffeic acid-conjugated amyloid-β C-terminal peptides.
Arai T; Ohno A; Mori K; Kuwata H; Mizuno M; Imai K; Hara S; Shibanuma M; Kurihara M; Miyata N; Nakagawa H; Fukuhara K
Bioorg Med Chem Lett; 2016 Nov; 26(22):5468-5471. PubMed ID: 27789140
[TBL] [Abstract][Full Text] [Related]
20. Filamentous Aggregates of Tau Proteins Fulfil Standard Amyloid Criteria Provided by the Fuzzy Oil Drop (FOD) Model.
Dułak D; Gadzała M; Banach M; Ptak M; Wiśniowski Z; Konieczny L; Roterman I
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
